August 10, 2017 Organoids are clusters of cultured cells self-organized into miniature replicas of organs. In this image, neural progenitor cells (NPCs) are green. As the brain organoids increase in size, multi-layer structures composed of NPCs develop with intermediate progenitors (not shown) and cortical layer neurons (red). Cell nuclei are depicted in blue. Credit: Cleber A. Trujillo, UC San Diego
An international team of scientists, led by University of California San Diego School of Medicine researchers, has created a human stem cell-based model of a rare, but devastating, inherited neurological autoimmune condition called Aicardi-Goutieres Syndrome (AGS). In doing so, the team was able to identify unusual and surprising underlying genetic mechanisms that drive AGS and test strategies to inhibit the condition using existing drugs.
Two repurposed FDA-approved drugs showed measurable effect, rescuing cells from the effects of AGS. The findings point to the promise of future clinical trials and to the utility of creating novel stem cell-based models of human diseases when no other models are available.
The findings are published in the August 10 online issue of Cell Stem Cell.
"Our approach can now be used to investigate other neurological conditions, like autism and schizophrenia and overlapping autoimmune disorders that dysfunction in similar ways," said Alysson Muotri, PhD, professor in the UC San Diego School of Medicine departments of Pediatrics and Cellular and Molecular Medicine, director of the UC San Diego Stem Cell Program and a member of the Sanford Consortium for Regenerative Medicine.
First described in 1984, AGS typically involves early-onset inflammation affecting the brain, immune system and skin. Its severity depends upon which genes are involvedthere are six typesbut usually results in pronounced physiological and psychological consequences, from microcephaly (an abnormally small head) and spasticity to skin and vision problems and joint stiffness, all appearing in the first year of life. The syndrome is progressive, resulting in death or a persistent vegetative state in early childhood. Currently, there is no cure; the only treatments are symptomatic or palliative.
The clinical features of AGS mimic those of viral infections acquired in utero, before birth, with increased levels of inflammatory markers and other signatures of inflammatory response. However, Muotri said there is no link between AGS and exogenous pathogens. Previous research has shown that AGS patients have mutations in genes critical to nucleic acid metabolism in the regulation of cellular immune response, among them a deficiency in an enzyme called TREX1, which helps prevent abnormal DNA from accumulating in cells.
Deeper probing into the pathogenesis of AGS has been difficult because animal models do not accurately mimic the human version of the disease. So Muotri, with colleagues, used embryonic stem cells and induced pluripotent stem cells (iPSCs) derived from AGS patients to create six cellular models of the condition. In the past, Muotri's lab has developed similar "disease-in-a-dish" neuronal models of autism, anorexia nervosa and Williams Syndrome, among other rare genetic neurological conditions.
From the iPSCs, they also created cerebral organoids or "mini-brains"larger clusters of neurons that organize themselves into a cortical structure, similar to a developing human cerebral cortex.
The researchers found that with TREX1 not functioning normally, all of the cell models displayed excess extra-chromosomal DNA and that a major source of the excess DNA came from LINE1 (L1) retroelements. L1s are repetitive sequences of DNA with the ability to autonomously copy-and-paste themselves within the human genome. In the past, they have been called "jumping genes" and, because their function within cells is largely unknown, "junk DNA."
However the term "junk DNA" is increasingly becoming a misnomer. In work published in 2005, for example, Muotri and colleagues reported that L1s have a high impact on brain cells compared to other tissues, suggesting an important, if so far mysterious, role in brain development.
Since then, he said, researchers around the world have investigated the role of L1s in creating a genetic mosaicism in the brain. "These are ancient, genomic parasites that replicate inside our cells. The majority of the current work is focusing on the impact of this genome mosaicism, but we decided to also look outside of the nucleus. And what we found was a big surprise."
In some of the AGS cell models created by the researchers, toxins from excess DNA built up. Others showed an abnormal immune response, secreting toxins that induced cell death in other cells. The combined effect in organoids was a massive reduction in neuron growth when the opposite should occur. "These models seemed to mirror the development and progression of AGS in a developing fetus," said Muotri. "It was cell death and reduction when neural development should be rising."
The cell death was trigged by the anti-viral response from the L1 molecules outside the nucleus. "We uncovered a novel and fundamental mechanism, where chronic response to L1 elements can negatively impact human neurodevelopment," said Charles Thomas, a former graduate student in the Muotri lab and first author of the study. "This mechanism seems human-specific. We don't see this in the mouse."
The researchers observed that AGS pathogenesis was similar to a retroviral infection and wondered whether existing HIV antiretroviral drugs might be effective in interfering in L1 replication. Two drugs were tested in the cell models: Stavudine and Lamivudine. Both drugs resulted in reduced L1 and cell toxicity. Cell model growth returned in all cell types and in the complex, differentiated colonies of nerve cells that comprise organoids.
The data supported the idea that HIV drugs could benefit AGS patients, Muotri said. A clinical trial led by study co-author Yanick Crow, MRCP, PhD, at Sorbonne Paris Cite University and the University of Manchester, has already started in Europe.
Muotri said the findings were illuminating and encouraging, providing a platform and impetus for further study of the pathology of neuroinflammation and drug discovery. "It's important to note that while this work focused on AGS, nerve cells in schizophrenia show an overabundance of L1 elementsand there is an overlap with other autoimmune disorders.
"This is a great example of how a fundamental basic research could be rapidly translated into clinics. Are there analogous mechanisms at work in these different diseases? Is this modeling strategy relevant for better understanding and treating them? These are questions we will now pursue."
Explore further: Researchers create model of anorexia nervosa using stem cells
More information: Charles A. Thomas et al, Modeling of TREX1-Dependent Autoimmune Disease using Human Stem Cells Highlights L1 Accumulation as a Source of Neuroinflammation, Cell Stem Cell (2017). DOI: 10.1016/j.stem.2017.07.009
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
- BCLI: Phase 3 ALS Data Expected by the End of November 2020 - Zacks Small Cap Research - August 7th, 2020
- Types of Stem Cell Transplantation | Stem Cell ... - August 7th, 2020
- Mesoblasts share price gained another 16% in July. Heres why. - Motley Fool Australia - August 7th, 2020
- Future Technological Prospects of Stem Cell Assay Market To 2030 - Owned - August 6th, 2020
- Biobanks Market Projected to be Resilient During 2025 Owned - Owned - August 6th, 2020
- Training neural circuits early in development improves response, study finds - University of Illinois News - August 6th, 2020
- New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19 - GlobeNewswire - August 6th, 2020
- Contract Manufacturing Services market for stem cells is expected to be worth over USD 2.5 billion by 2030, claims Roots Analysis - Market Research... - August 6th, 2020
- INmune Bio, Inc. Announces Second Quarter 2020 Results and Provides Business UpdateThe company will host an earnings call: Today, August 5 at 4:30 PM... - August 6th, 2020
- Global Cell Analysis Instruments Market (2020 to 2025) - Growth, Trends, and Forecasts - Yahoo Finance UK - August 5th, 2020
- HKUMed researchers first discovered SARS-CoV-2 infects human neural progenitor cells and brain organoids - Mirage News - August 4th, 2020
- Electromedical Inc. Accelerates Corporate Expansion and Product DevelopmentAnnounces the Opening of First European Office For the Development of New... - August 4th, 2020
- Circulating Tumor Cells (CTC) Market 2020-2026 is Slated to Witness Tremendous Growth | Global Players NanoString Technologies, Inc., Miltenyi Biotec... - August 4th, 2020
- COVID-19 Impacts: Hematopoietic Stem Cells Transplantation (HSCT) Market will Accelerate at a CAGR of Almost 6% Through 2020-2024 | Demand for... - August 4th, 2020
- Gyroscope Announces Appointment of Leaders in Retinal Disease, Gene Therapy and the Complement System to Its Clinical and Scientific Advisory Boards -... - August 4th, 2020
- How can nanomedicine be applied to cannabis? - Leafly - August 3rd, 2020
- Annual Luau and Legends of Surfing Invitational to make virtual waves - For the first time ever surfers scientists physicians and survivors will come... - August 3rd, 2020
- Automated Cell Culture Systems Market to Record Strong Growth due to High Demand for Advanced Treatment of Chronic Conditions, Future Market Insights... - August 3rd, 2020
- CarthroniX President/Chairman of the Board R. Rex Parris and Carrol Parris Donate $50,000 in Support of Life Extension Research - PRNewswire - August 3rd, 2020
- UPDATE - Cytovia Therapeutics Acquires Worldwide Rights to CytoImmune Therapeutics' First-In-Class EGFR Dual-targeting CAR for NK Cell Treatment of... - August 3rd, 2020
- FDA-approved treatment puts rare cancer with skin manifestations on the map - Dermatology Times - August 3rd, 2020
- Stem Cell Assay Market To 2026: Growth Analysis By Manufacturers, Regions, Types And Applications - Research Newspaper - August 3rd, 2020
- More on the language of immunity - Cosmos - August 3rd, 2020
- Regenerative Medicine Products to Discern Magnified Growth During 2019-2025 - Owned - August 2nd, 2020
- Cryopreservation Media Market Highly Favourable with new Demand to the Growth Rate by 2025 - Market Research Posts - August 1st, 2020
- Cell and Gene Therapy Market Size to Reach over $14 Billion by 2025 - Arizton - PRNewswire - July 31st, 2020
- Meso Numismatics Update on 2nd Transaction with Global Stem Cells - GlobeNewswire - July 31st, 2020
- Regenerative Medicine Market 2020 | Research Objectives and Methodology, Growth Analysis, Top Manufacturers Sales, and Cost Structures Forecast 2024 -... - July 31st, 2020
- Cerus Corporation Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood Systems - BioSpace - July 31st, 2020
- Global Cell Expansion Market, Forecast to 2025 - Increasing Incidence of Chronic Diseases and Government Investments for Cell-based Research -... - July 30th, 2020
- The function of the thymus and its impact on modern medicine - Science Magazine - July 30th, 2020
- AlloVir's IPO Raises $276M to Test Cell Therapies in Transplant Patients - Xconomy - July 30th, 2020
- Cerus Corporation Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood Systems - Business Wire - July 30th, 2020
- Global Cell Expansion Market, Forecast to 2025 - Increasing Incidence of Chronic Diseases and Government Investments for Cell-based Research - Yahoo... - July 30th, 2020
- UW researchers devise approach to treat rare, incurable form of blindness - University of Wisconsin-Madison - July 30th, 2020
- A Year After Getting Gene Therapy, Boys With Muscular Dystrophy Are Healthier and Stronger - Singularity Hub - July 30th, 2020
- Global Regenerative Medicine Market 2020| Industry Demand, Share, Global Trend, Industry News, Business Growth, Top Key Players Update, Business... - July 30th, 2020
- Qkine bolsters top team in first phase of scale-up - Business Weekly - July 30th, 2020
- $30+ Billion Cell Expansion Market by Product, Cell Type, Application, End-user and Region - Forecast to 2025 - ResearchAndMarkets.com - Business Wire - July 30th, 2020
- Waveguide Combiners & Dividers Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis, And Key... - July 30th, 2020
- Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine and the Ontario Institute for Regenerative Medicine Partner to Boost... - July 29th, 2020
- It's Time to 'Be The Match,' Help Save a Life - SCVNEWS.com - July 29th, 2020
- American Academy of Stem Cell Physicians is Hosting an FDA Safety Panel, Session is Now Free to the Public - PRNewswire - July 29th, 2020
- Genfit throws in the towel on NASH, exiting a tumultuous field full of bright market prospects and lethal R&D setbacks - Endpoints News - July 29th, 2020
- Stem Cell & Regenerative Medicine Specialist - Greenville ... - July 28th, 2020
- Another Voice: Terminally ill New Yorkers need a peaceful dying option - Buffalo News - July 28th, 2020
- Cleave Therapeutics Announces Commencement of a Phase 1 Clinical Study of CB-5339, A Valosin-Containing Protein (VCP)/p97 Inhibitor, in Patients with... - July 28th, 2020
- Trump looks to hammer down drug prices with 4 executive orders - Endpoints News - July 28th, 2020
- Therapeutic Solutions International Files Patent on Ability of QuadraMune Ingredient Pterostilbene to Reduce Inflammation while Stimulating Brain... - July 28th, 2020
- Duvelisib May Reduce Lung Inflammation in Severe COVID-19 Cases - OncLive - July 27th, 2020
- A breakthrough: Stem cell therapy cures Covid-19 The Manila Times - The Manila Times - July 27th, 2020
- UAE hails success of first bone marrow transplant - The National - July 27th, 2020
- Drug target for aggressive breast cancer found by team of UK and US scientists - iNews - July 27th, 2020
- Rethinking the Science of Skin - The New Yorker - July 27th, 2020
- Boehringer Ingelheim acquires GST to strengthen its stem cell capabilities in Animal Health - Business Wire - July 27th, 2020
- Why I Walk To End Alzheimer's - TAPinto.net - July 26th, 2020
- Stem Cell Market Status by Upcoming Trends 2020 Growth Drivers | Competitive Strategy, Regional Outlook with SWOT Analysis till 2024 - Owned - July 25th, 2020
- Sobi will file for a re-examination of emapalumab in Europe following negative opinion by CHMP | Antibodies | News Channels - PipelineReview.com - July 24th, 2020
- The Long Game of Coronavirus Research - The New Yorker - July 23rd, 2020
- Current research: Exosome Technologies Market Report- Growth with Top Companies Capricor, Codiak and Evox Therapeutics - WhaTech Technology and... - July 23rd, 2020
- Calling Attention to Treatment Considerations in MCL - OncLive - July 22nd, 2020
- Research Roundup: Global methane emissions at all-time high, neuronal pathway prevents relapse, possible drug target to help fight infectious diseases... - July 22nd, 2020
- Citius Pharmaceuticals Forms Scientific Advisory Board for the Planned Development of its Proprietary Treatment for Acute Respiratory Disease... - July 22nd, 2020
- Impact of Outbreak of COVID-19 on Organoids Market : Global Industry Analysis, Forecast 2027 - 3rd Watch News - July 22nd, 2020
- Stem Cell Therapy and Regenerative Medicine with Dr. Mayo ... - July 21st, 2020
- Agenus To Participate in a Panel on Cell Therapy for Infectious Diseases at the B. Riley Virtual Infectious Disease Summit - PRNewswire - July 21st, 2020
- COVID-19 Fibroblast Based Cell Therapy Candidate Shown to Reduce Lung Scarring in Aggressive Animal Model - Tyler Morning Telegraph - July 21st, 2020
- Growing Demand for Anti Aging Medicine Market to Significantly Increase Revenues Through 2026 - 3rd Watch News - July 21st, 2020
- COVID-19 Impact on Regenerative Medicine Market 2020: Global Industry Size, Growth, Emerging Trends, Business Opportunities, SWOT Analysis by Top Key... - July 21st, 2020
- Orthopedic Regenerative Medicine Market Analysis and Forecast 2020: By Key players Curasan, Inc., Carmell Therapeutics Corporation, Anika... - July 21st, 2020
- Amniotic Membranes Market is Projected to Expand at a CAGR of ~10% from 2019 to 2027 - 3rd Watch News - July 21st, 2020
- Cell Expansion Market is Expected to Reach $30.1 billion by 2025 | Key Players are Thermo Fisher Scientific (US), Danaher (US), Becton, Dickinson and... - July 20th, 2020
- Insights on the Cell Culture Media Market to 2019 to 2029 Persistence Market Research - Cole of Duty - July 20th, 2020
- 3D Cell Culture Market 2020 to 2026 Analysis and Forecast by Type, Application and Top Manufactures - 3rd Watch News - July 20th, 2020
- Cell Separation Market Demand Status with Trends Analysis 2020 | Global Industry Size, Share, Explosive Factors of Key Players, Future Opportunities... - July 20th, 2020
- Notch Therapeutics Appoints David Main as President and Chief Executive Officer to Advance the Company's Novel Gene-Edited, iPSC-Derived Immune Cell... - July 20th, 2020
- 3D Cell Culture Market 2020 with Top Countries Data, Global Industry Forecasts Analysis, Top Company Profiles, Competitive Landscape and Key Regions... - July 20th, 2020
- Cell Culture Media Market with (Covid-19) Impact Analysis: In-depth Analysis, Global Market Share, Top Trends, Professional & Technical Industry... - July 19th, 2020
- Adipose Stem Cell Regenerative Medicine in 21st Century ... - July 19th, 2020
- 3D Cell Culture Market 2020 | Remarkable Growth Factors with Industry Size & Share, New Innovations of Leading Players & Forecast till 2024 -... - July 19th, 2020